The minimal effective exemestane dose for endocrine activity in advanced breast cancer.
Bajetta E, Zilembo N, Noberasco C, Martinetti A, Mariani L, Ferrari L, Buzzoni R, Greco M, Bartoli C, Spagnoli I, Danesini GM, Artale S, Paolini J.
Bajetta E, et al. Among authors: bartoli c.
Eur J Cancer. 1997 Apr;33(4):587-91. doi: 10.1016/s0959-8049(96)00494-7.
Eur J Cancer. 1997.
PMID: 9274439
Clinical Trial.